Lineage
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Lineage, Inc. is the world’s largest global temperature-controlled warehouse REIT with a network of 498 strategically located facilities totaling approximately 87 million square feet and approximately...
Latest News
6 days ago · marketbeat.com
What Lineage (LINE) Said on Its Q3 Earnings CallLineage NASDAQ: LINE lowered its full-year adjusted EBITDA outlook after rising transportation costs and weaker-than-expected seasonal warehouse activity weighed on its third-quarter results. The cold-storage company maintained the midpoint of its adjusted funds from operations, or AFFO, per-share forecast, helped by lower spending and taxes.
6 days ago · seekingalpha.com
Lineage, Inc. (LINE) Q3 2026 Earnings Call TranscriptLineage, Inc. ( LINE ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST Company Participants Ki Bin Kim - Vice President of Investor Relations W. Lehmkuhl - CEO, President & Director Robb LeMasters - Chief Financial Officer Conference Call Participants Blaine Heck - Wells Fargo Securities, LLC, Research Division Michael Griffin - Evercore ISI Institutional Equities, Research Division Ronald Kamdem - Morgan Stanley, Research Division Michael Goldsmith - UBS Investment Bank, Research Division Nicholas Joseph - Citigroup Inc., Research Division Caitlin Burrows - Goldman Sachs Group, Inc., Research Division Daniel Guglielmo - Capital One Securities, Inc., Research Division Michael Carroll - RBC Capital Markets, Research Division Michael Lewis - Truist Securities, Inc., Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Viktor Fediv - Scotiabank Global Banking and Markets, Research Division Vikram Malhotra - Mizuho Securities USA LLC, Research Division Presentation Operator Hello, everyone.
7 days ago · zacks.com
Lineage, Inc. (LINE) Tops Q3 FFO and Revenue EstimatesLineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.73 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to FFO of $0.85 per share a year ago.
7 days ago · zacks.com
Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesThe headline numbers for Lineage, Inc. (LINE) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
7 days ago · globenewswire.com
Lineage, Inc. Reports Third-Quarter 2026 Financial ResultsNOVI, Mich., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced its financial results for the third quarter of 2026.
12 days ago · zacks.com
Lineage, Inc. (LINE) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresBeyond analysts' top-and-bottom-line estimates for Lineage, Inc. (LINE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.
19 days ago · prnewswire.com
PREFORMED LINE PRODUCTS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTSCLEVELAND, Oct. 28, 2026 /PRNewswire/ -- Preformed Line Products Company (NASDAQ: PLPC) today reported financial results for its third-quarter of 2026. Q3 2026 highlights: Quarterly net sales of $209.5 million, an increase of 18% from Q3 2025.
24 days ago · prnewswire.com
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERNearly 80% of Patients Were Alive at One Year Versus 53% with IMFINZI Alone and Progression-Free Survival More Than Tripled Late-Breaking Phase 3 DeLLphi-305 Results Presented in ESMO Presidential Symposium and Simultaneously Published in The New England Journal of Medicine Longer DeLLphi-303 Follow-Up Data Showed Median Overall Survival Exceeded 37 Months in First-Line Maintenance with IMDELLTRA and Either IMFINZI or TECENTRIQ® THOUSAND OAKS, Calif., Oct. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% as a first-line maintenance treatment for extensive stage small cell lung cancer (ES-SCLC) (hazard ratio [HR]: 0.42; 95% confidence interval [CI]: 0.32, 0.54; P
1 month ago · globenewswire.com
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARENEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU ) announced today that its Board of Directors declared on October 16, 2026 a quarterly cash dividend of $0.35 per common share, payable on November 10, 2026, to stockholders of record on October 26, 2026. The Company has 9,382,098 shares of common stock outstanding as of October 16, 2026.
1 month ago · globenewswire.com
Lineage to Report Third-Quarter 2026 Financial Results on November 9, 2026NOVI, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the third quarter of 2026 on Monday, November 9, 2026, after market close. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Tuesday, November 10, 2026.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove LINE